GE HealthCare Technologies Operating Income 2020-2025 | GEHC
GE HealthCare Technologies annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- GE HealthCare Technologies operating income for the quarter ending March 31, 2025 was $628M, a 16.51% increase year-over-year.
- GE HealthCare Technologies operating income for the twelve months ending March 31, 2025 was $2.714B, a 12.38% increase year-over-year.
- GE HealthCare Technologies annual operating income for 2024 was $2.625B, a 7.8% increase from 2023.
- GE HealthCare Technologies annual operating income for 2023 was $2.435B, a 3.45% decline from 2022.
- GE HealthCare Technologies annual operating income for 2022 was $2.522B, a 9.77% decline from 2021.
| GE HealthCare Technologies Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $2,625 |
| 2023 | $2,435 |
| 2022 | $2,522 |
| 2021 | $2,795 |
| 2020 | $2,720 |
| 2019 | $2,124 |
| GE HealthCare Technologies Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $628 |
| 2024-12-31 | $803 |
| 2024-09-30 | $675 |
| 2024-06-30 | $608 |
| 2024-03-31 | $539 |
| 2023-12-31 | $689 |
| 2023-09-30 | $617 |
| 2023-06-30 | $570 |
| 2023-03-31 | $559 |
| 2022-12-31 | $777 |
| 2022-09-30 | $605 |
| 2022-06-30 | $631 |
| 2022-03-31 | $509 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.583B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
| Boston Scientific (BSX) | United States | $151.436B | 37.91 |
| Stryker (SYK) | United States | $144.721B | 30.26 |
| EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
| Medtronic (MDT) | Ireland | $110.247B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.320B | 28.03 |
| Agilent Technologies (A) | United States | $32.988B | 21.51 |
| Terumo (TRUMY) | Japan | $26.976B | 35.04 |
| Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
| Insulet (PODD) | United States | $21.652B | 84.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
| Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
| Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
| Perrigo (PRGO) | Ireland | $3.636B | 9.22 |
| Haemonetics (HAE) | United States | $3.462B | 15.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.203B | 26.62 |
| ICU Medical (ICUI) | United States | $3.152B | 23.24 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
| AtriCure (ATRC) | United States | $1.579B | 0.00 |
| Acuren (TIC) | United States | $1.283B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
| Neogen (NEOG) | United States | $1.035B | 13.25 |
| Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.853B | 8.59 |
| Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| Evolus (EOLS) | United States | $0.605B | 0.00 |
| Owens & Minor (OMI) | United States | $0.562B | 4.67 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
| Valneva SE (VALN) | France | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Quanterix (QTRX) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.95 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.45 |
| TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 61.29 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.03 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |